Clovis Oncology, Inc. Finance Lease, Principal Payments
Clovis Oncology, Inc. reported Finance Lease, Principal Payments of $780.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:FinanceLeasePrincipalPayments · last filed 2022-11-09
- Clovis Oncology, Inc. finance lease, principal payments for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Clovis Oncology, Inc. finance lease, principal payments for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- Clovis Oncology, Inc. finance lease, principal payments for the quarter ending 2021-06-30 was $394.00K, a 8.24% increase year-over-year.
- Clovis Oncology, Inc. finance lease, principal payments for the quarter ending 2021-03-31 was $386.00K, a 8.12% increase year-over-year.
- Clovis Oncology, Inc. finance lease, principal payments for fiscal 2021 was $780.00K, a 46.94% decline from fiscal 2020.
- Clovis Oncology, Inc. finance lease, principal payments for fiscal 2020 was $1.47M, a 31.84% increase from fiscal 2019.
- Clovis Oncology, Inc. finance lease, principal payments for fiscal 2019 was $1.11M.
| Period end | Finance Lease, Principal Payments 3 month | Finance Lease, Principal Payments 6 month | Finance Lease, Principal Payments 9 month | Finance Lease, Principal Payments 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $394.00K derived: sum of 3 quarters · filed 2022-11-09 | $780.00K 10-K · filed 2022-02-24 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $394.00K derived: sum of 2 quarters · filed 2022-11-09 | $780.00K 10-Q · filed 2022-11-09 | $1.16M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $394.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $780.00K 10-Q · filed 2022-08-08 | $1.16M derived: sum of 3 quarters · filed 2022-08-08 | $1.53M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $386.00K 10-Q · filed 2022-05-05 | $764.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.14M derived: sum of 3 quarters · filed 2022-05-05 | $1.50M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $749.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.11M derived: sum of 3 quarters · filed 2022-02-24 | $1.47M 10-K · filed 2022-02-24 |
| 2020-09-30 | $371.00K 10-Q · filed 2020-11-05 | $735.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.09M 10-Q · filed 2021-11-03 | $1.44M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $364.00K 10-Q · filed 2020-08-07 | $720.00K 10-Q · filed 2021-08-04 | $1.07M derived: sum of 3 quarters · filed 2022-02-24 | $1.33M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $357.00K 10-Q · filed 2021-05-05 | $707.00K derived: sum of 2 quarters · filed 2022-02-24 | $967.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.22M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $610.00K derived: sum of 2 quarters · filed 2022-02-24 | $865.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.11M 10-K · filed 2022-02-24 |
| 2019-09-30 | $260.00K 10-Q · filed 2020-11-05 | $515.00K derived: sum of 2 quarters · filed 2020-11-05 | $765.00K 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $255.00K 10-Q · filed 2020-08-07 | $505.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $250.00K 10-Q · filed 2020-05-06 |